ISTH 2024

Founded in 1969, the ISTH is the leading worldwide not-for-profit organization dedicated to advancing the understanding, prevention, diagnosis and treatment of conditions related to thrombosis and hemostasis. The ISTH boasts more than 7,000 clinicians, researchers and educators working together to improve the lives of patients in more than 100 countries around the world.

Among its highly regarded activities and initiatives are education and standardization programs, clinical guidance and practice guidelines, research activities, meetings and congresses, peer-reviewed publications, expert committees and World Thrombosis Day on October 13.

Like every year, this global event takes place in the heart of a capital city. This year, the ISTH will be held in Bangkok, Thailand, from 22 to 26 June 2024, a destination particularly renowned for its cultural richness. Thousands of experts in thrombosis, haemostasis and vascular biology come together at this international event to present the latest advances, discuss the latest scientific knowledge and share recent clinical applications designed to improve patient care.

With an extensive programme of educational sessions, cutting-edge lectures, medical industry exhibitions and professional networking opportunities, this congress is an opportunity to showcase scientific progress.

Dr Charlotte KAWECKI, R&D Director at PepReDep, will be representing the Anasabe Group and its subsidiaries Cryopep and PepReDep at the conference. She will present the results of her research on a poster entitled “Study of new single domain of antibodies against factor IX as diagnostic agents”, focusing on the characterisation of 8 anti-FIX VHHs with a view to developing diagnostic tools; she will explain their specificities, cross-reactivities, affinities and potential effects on coagulation.

Location: poster area, n°PB0078

Presentation: 23/06/2024

Title: “Study of new single domain of antibodies against factor IX as diagnostic agents”.

To contact Dr. KAWECKI, follow his LinkedIn here

➡ Pentapharm

➡ Precision Biologic

➡ Technoclone

➡ Zacros which will be presenting the T-TAS® 01 (Total Thrombus formation analysis system) analyser at a private seminar on 24 June, with a product demonstration.

For more information and a map of our partners’ locations, click here